Navigation Links
Prof Samir K Brahmachari, Dr MRS Rao Jointly Win Bio-medical Research Award

Prof. Samir K Brahmachari and Dr. MRS Rao will be jointly awarded the Dr B R Ambedkar Centenary Award for the year 2005 for their outstanding contribution in the field of bio-medical research.

The award carries a cash prize of rupees one lakh.

Besides, the Indian Council of Medical Research (ICMR) has selected 31 biomedical scientists from across the country to be honoured for their outstanding contributions in research work for 2004-2005.

The awards will be presented by Union Health Minister Anbumani Ramadoss later this week.

Institute of Genomics and Integrative Biology Director Dr. Brahmachari is renowned for his contribution in molecular genetics of neurological and psychiatric disorders.

He had made fundamental discoveries in the areas of genomics that led others to develop approaches for cancer therapeutics.

His most significant contribution is in the identification of three novel genes of SARS virus.

Dr. Rao, President of the Jawaharlal Nehru Centre for Advanced Scientific Research at Bangalore, has used several ingenious and novel methods to identify mammalian recombination hotspots in mouse and humans.

He is a co-discoverer of the gene involved in a particular type of colon cancer and is credited to have initiated genomic approaches towards understanding various biological processes in both normal and diseased conditions.

The biennial Ambedkar Centenary Award was instituted in 1991-92 by the ICMR as part of the birth centenary celebrations of Dr B R Ambedkar.


'"/>




Page: 1

Related medicine news :

1. India and Pakistan Jointly to Fight Against Polio, Avian Flu
2. Cardiovascular Diseases in India To be Studied Jointly By John Hopkins And Apollo Hospitals
3. India and China Agrees to Promote Healthcare Jointly
4. China, France to Jointly Develop Traditional Chinese Medicines
5. British MP Stress the Need to Fight Against TB Jointly With India
6. GSK, TCS to Jointly Set Up Drug Development Center
7. Malaria and HIV Jointly Affects Pregnant Women and Their Infants
8. Kidney Stones - Interesting New Research implicates bacteria as its cause
9. Researchers urge caution in using ear tube surgery
10. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
11. Researchers Scale to assess the Severity of Epilepsy in Kids
Post Your Comments:
(Date:12/3/2008)...ive disease, researchers say , , WEDNESD... promote the growth of new nerves that are associa...report. , It,s been shown that prostate cancer ...t study to find that prostate tumors actually prom... Medicine, Houston. The new finding is comparable...
(Date:12/3/2008)...e fascinated by their brains,the way they work, ...,Association for the Advancement of Science (AAAS)... use that fascination to engage middle and high sc... of why they shouldn,t drink,alcohol. , "P...heir teens not to,drink alcohol, particularly dur...
(Date:12/3/2008)...- Health Analytic Services,today announced its Th..., and,fitness information on iPhone and iPod touc...application provides mobile access to TheCarrot.co...ser,s well-being. , "Powerful wireless conn...face has enabled us to create the perfect companio...
(Date:12/3/2008)...Smith Laboratories, Inc.,announced its plans to m...capsule prenatal vitamin with the most plant-based...sidering pregnancy, pregnant women and new mothers...ife,sDHA(TM), the DHA in PreNexa(TM), is derived f...n.(1,7) It is also the same DHA source,used in i...
Breaking Medicine News(10 mins):Health News:Prostate Cancer Stimulates Nerve Growth 2Health News:When 'Just Say No' Isn't Enough: Try Science 2Health News:TheCarrot.com Launches Mobile Health and Wellness Tracking Application on Apple App Store 2Health News:First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-Based DHA Now Available 2Health News:First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-Based DHA Now Available 3Health News:First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-Based DHA Now Available 4
...of Pittsburgh researchers are currently testing th...n with traumatic brain injury. Hypothermia treatme...ypoxic ischemia in children, but its effectiveness...es has not yet been studied. Hypothermia decreases...
...udy by researchers at the University of Durham in ...re benefit to the long list of already existing on...reast-fed in bed are at much less risk of being sm...e study included 40 couples and their babies who w...
...in Kolkatta, India recently received a patient, a ...said to be suffering from a rare disease caused du...ase occurs only in one out of 10 million children....spital with complaints of blood in stool. On detec...
... published in the journal, Molecular Psychiatry su...marker which may make people susceptible to sleepw...ects around half of young children and up to 3 per..., it may sometimes cause injuries to the person wi...
Other Medicine News:
(Date:12/2/2008)... -- Micromet, Inc. (Nasdaq: MITI ), a biopharmac...bodies for the treatment of cancer, inflammation a...s entered into an agreement expanding its Committe...e Capital Limited, a private investment group. Un...mmitted to provide up to $75 million of capital du...
(Date:12/1/2008)...Ltd today announced the initiation of a Phase 1/2 ...ve JAK2 inhibitor, in leading medical centers in A...ofibrosis (CIMF). , , The trial is designe...8 in patients with CIMF and is expected to enrol u...ill assess the safety profile and evaluate the pha...
(Date:12/1/2008)...rstCall/ -- Genaera Corporation (Nasdaq: GENR )... in study MSI-1436C-102 (Study 102), the multiple ...I-1436) in overweight and obese type 2 diabetics. ...of type 2 diabetes and obesity which works central... pathways through the highly selective inhibition ...
(Date:11/30/2008)...wswire/ -- Older adults who exercise regularly sho...er of small blood vessels in the brain, according ...of the Radiological Society of North America (RSNA...sity of North Carolina ( UNC) - Chapel Hill , is ...ho exercise to brain scans of those who do not. ,...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Caliper Life Sciences to Present at Cowen and Company 28th Annual Health Care Conference 3827 1Virtual reality and computer technology improve stroke rehabilitation 13903 1Virtual reality and computer technology improve stroke rehabilitation 13903 2Confronting the challenge of antimicrobial resistance 13901 1Confronting the challenge of antimicrobial resistance 13901 2Confronting the challenge of antimicrobial resistance 13901 3What Will You Do 3F Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10 17 13898 1What Will You Do 3F Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10 17 13898 2What Will You Do 3F Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10 17 13898 3What Will You Do 3F Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10 17 13898 4
...t Potential Benefit of Unique OROS(R),Formulation,... drug abuse,remains an ongoing concern for parents... Attention Deficit Hyperactivity Disorder,(ADHD). ...ing of,the American Psychiatric Association highli...idate had fewer reports of abuse and,lower abuse-r...
..., 2007-The chemotherapy drug,docetaxel currently o...prostate cancer. That is the result of a now,publi...the two most,widely used chemotherapy drugs. When ...as cut by more than 50% than when using the,next-b...o treat prostate cancer has rapidly,grown in impor...
Other Medicine Technology:New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 2New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 3New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 4New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 5Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy 2Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy 3
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability.
... Aeroset was designed with a whole new level of sp...s up to 2,000 tests per hour-a higher level of thr...of efficiency and patient turn-around time. Consid... allows for easy to use multi-view screens with au...
The Advia IMS integrates a full menu of both immunoassay and chemistry tests.
The Roche Diagnostics Task Targeted Automation VS II is a state-of-the-art automation of pre- and post-analytical steps in the laboratories: decapping, sorting / archiving of primary tubes and aliqu
Medicine Products: